Harleysville, PA, United States of America

Anthony W Shaw

This inventor holds 35 USPTO granted patents and 9 published patent applications, plus 1 CIPO patent and 14 EPO patents, primarily in Cytotoxic Agents. Top assignees: Merck + Co., Inc., Merck Sharp + Dohme Corp., Sirna Therapeutics, Inc.. Active years: 1998-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Anthony W Shaw. Retrieved from https://idiyas.com/inventor/anthony-w-shaw

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 35 (Patent Applications = 9)

% Patents Active = 88.6

CIPO Patents = 1 (Patent Applications = 3)

EPO Patents = 14 (Patent Applications = 14)

Average Co-Inventor Count = 4.9

ph-index = 11

Forward Citations = 281(Granted Patents)

Location History:

Rahway, NJ (US) (2002)
Lansdale, PA (US) (1998 - 2003)
Harlesyville, PA (US) (2007)
West Point, PA (US) (2011 - 2021)
Harleysville, PA (US) (2005 - 2023)

Company Filing History:

Merck Sharp + Dohme Corp.

patents

6 out of 140

Sirna Therapeutics, Inc.

patents

4. 3 out of 72

Merck Sharp & Dohme LLC

patents

5. 1 out of 5

Sima Therapeutics, Inc.

patents

6. 2 out of 834,601

Other

patents

Years Active: 1998-2026

Loading Chart...

Areas of Expertise:

Cytotoxic Agents

Tetrahydroquinazoline

Oligonucleotide Delivery

P2X3 Antagonists

CGRP Antagonists

Prenyl-Protein Transferase

Farnesyl-Protein Transferase

Chemical Entities

35 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12753187 - Amido-substituted pyridyl compounds and methods of use thereof for the treatment of herpesviruses (2026-10-06),

2. 12558357 - Tetrahydroquinazoline derivatives as selective cytotoxic agents (2026-02-24),

3. 12492183 - Tetrahydroquinazoline derivatives as selective cytotoxic agents (2025-12-09),

4. 12304925 - Tetragalnac and peptide containing conjugates and methods for delivery of oligonucleotides (2025-05-20),

5. 11648250 - Tetrahydroquinazoline derivatives as selective cytotoxic agents (2023-05-16),

6. 11117917 - Tetragalnac and peptide containing conjugates and methods for delivery of oligonucleotides (2021-09-14),

7. 10221205 - Tetragalnac and peptide containing conjugates and methods for delivery of oligonucleotides (2019-03-05),

8. 10214742 - Tetragalnac containing conjugates and methods for delivery of oligonucleotides (2019-02-26),

9. 9840531 - Tetragalnac and peptide containing conjugates and methods for delivery of oligonucleotides (2017-12-12),

10. 9655976 - Tetragalnac and peptide containing conjugates and methods for delivery of oligonucleotides (2017-05-23),

11. 9540639 - Tetragalnac containing conjugates and methods for delivery of oligonucleotides (2017-01-10),

12. 8691580 - Single chemical entities and methods for delivery of oligonucleotides (2014-04-08),

13. 8598209 - P2X3, receptor antagonists for treatment of pain (2013-12-03),

14. 8039460 - CGRP receptor antagonists (2011-10-18),

15. 7994325 - CGRP receptor antagonists (2011-08-09),

As much as I'd love to help you out with that request, my expertise lies in the sphere of innovations, inventions, inventors, patent attorneys, assignees, and patents. If you have any questions related to these topics, feel free to ask, and I'll be happy to assist you!

Profile summary based on public USPTO records.